Benzinga - by Lisa Levin, Benzinga Editor.
Gainers
- Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withdrawal period of study C602 of DCCR for Prader-Willi Syndrome.
- Femasys Inc. (NASDAQ: FEMY) surged 244% to $1.1410 after the company received FDA 510(k) clearance for FemaSeed, an infertility treatment designed to deliver sperm directly to where conception occurs in a woman's fallopian tube.
- Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) shares gained 77.3% to $18.50. Alfasigma agreed to acquire Intercept Pharmaceuticals for $19.00 per share in cash.
- Immunovant, Inc. (NASDAQ: IMVT) jumped 75.6% to $35.60 after the company announced initial IMVT-1402 Phase 1 SAD and 300 mg subcutaneous MAD results.
- Tharimmune Inc (NASDAQ: THAR) shares gained 39.5% to $0.3090 after falling around 5% on Monday.
- Acasti Pharma Inc. (NASDAQ: ACST) gained 27.1% to $2.2250. Acasti announced a $7.5 million private placement equity financing.
- Cano Health, Inc. (NYSE: CANO) surged 24.2% to $0.3380. Cano Health said it sold substantially all of the assets associated with the operation of Cano Health's senior-focused primary care centers in Texas and Nevada to CenterWell Senior Primary Care.
- Bullfrog AI Holdings, Inc. (NASDAQ: BFRG) gained 23.6% to $3.5499. Bullfrog AI announced data from its preclinical study investigating the anti-cancer activity of a novel prodrug of mebendazole for glioblastoma.
- Avalo Therapeutics, Inc. (NASDAQ: AVTX) gained 21.9% to $0.1987 after jumping over 36% on Monday. Avalo Therapeutics reported the payoff of the remainder of its $35 million debt owed to Horizon Technology Finance.
- Adaptive Biotechnologies Corporation (NASDAQ: ADPT) shares climbed 21.2% to $6.16. Adaptive recently announced the launch of Epic integration for clonoSEQ.
- Infobird Co., Ltd (NASDAQ: IFBD) shares gained 19.7% to $0.1561. Infobird recently announced receipt of delinquency notification letter from the Nasdaq.
- ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) gained 18.8% to $4.28 after Director Rajeev Shah acquired a total of 2,700,000 shares an average price of $3.03 for roughly $8.18 million.
- Roivant Sciences Ltd. (NASDAQ: ROIV) gained 17% to $11.94 after the company announced initial IMVT-1402 Phase 1 SAD and 300 mg subcutaneous MAD results.
- Verve Therapeutics, Inc. (NASDAQ: VERV) rose 16.6% to $13.25. Verve Therapeutics to unveil interim data on VERVE-101 at the American Heart Association's Event.
- Pliant Therapeutics, Inc. (NASDAQ: PLRX) gained 15% to $16.77 after the company announced bexotegrast met its primary and secondary endpoints in the Phase 2a liver fibrosis trial.
- Fisker Inc. (NYSE: FSR) rose 14.2% to $6.06 after the company announced that deliveries are set to ramp up.
- Planet Green Holdings Corp. (NYSE: PLAG) surged 14.1% to $0.6470.
- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) rose 13.2% to $1.01.
- Adaptive Biotechnologies Corporation (NASDAQ: ADPT) gained 12.4% to $5.71.
- Acutus Medical, Inc. (NASDAQ: AFIB) jumped 11.7% to $0.6601.
- Aclarion, Inc. (NASDAQ: ACON) gained 11.4% to $0.39.
- Vera Therapeutics, Inc. (NASDAQ: VERA) climbed 10.3% to $15.69 as HC Wainwright & Co maintained a Buy rating on the stock and raised its price target from $10 to $25.
- Blue Star Foods Corp. (NASDAQ: BSFC) rose 8.6% to $0.2520 after dipping 20% on Monday.
- NightHawk Biosciences, Inc. (NASDAQ: NHWK) gained 7.5% to $0.57.
- Precigen, Inc. (NASDAQ: PGEN) rose 7.4% to $1.44.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares fell 68.7% to $0.7990 after the company priced its $8 million public offering of 15.7 million shares at $0.51 per share.
- Murphy Canyon Acquisition Corp. (NASDAQ: CDT) fell 35.7% to $6.67 after dipping 38% on Monday.
- Davis Commodities Limited (NASDAQ: DTCK) declined 33.2% to $3.15. The company recently priced its IPO at $4 per share.
- Molekule Group, Inc. (NASDAQ: MKUL) fell 28.8% to $0.2064.
- Polished.com Inc. (NYSE: POL) fell 25.2% to $0.0928 after surging 40% on Monday.
- United Natural Foods, Inc. (NYSE: UNFI) fell 23.3% to $14.51 after the company reported mixed fourth-quarter financial results and issued guidance.
- MicroAlgo Inc. (NASDAQ: MLGO) fell 19.2% to $2.43.
- Genetron Holdings Limited (NASDAQ: GTH) fell 18.2% to $0.7201.
- Greenfire Resources Ltd. (NYSE: GFR) declined 16.4% to $6.52.
- Novo Integrated Sciences, Inc. (NASDAQ: NVOS) fell 14.9% to $0.2261.
- Ebix, Inc. (NASDAQ: EBIX) dipped 12.8% to $10.36.
- New Pacific Metals Corp. (NYSE: NEWP) declined 12.2% to $1.9487. New Pacific Metals announced CAD$35 million bought deal financing.
- Greenfire Resources Ltd. (NYSE: GFR) fell 11.5% to $6.90.
- Biophytis S.A. (NASDAQ: BPTS) fell 11.2% to $1.4099. Biophytis shares jumped over 72% on Monday after the company and Skyepharma announced a partnership agreement for the production of regulatory batches of Sarconeos (BIO101) for severe forms of Covid-19.
- Roadzen, Inc. (NASDAQ: RDZN) fell 10.3% to $4.8135.
- Akili, Inc. (NASDAQ: AKLI) declined 9.4% to $0.5130.
- FaZe Holdings Inc. (NASDAQ: FAZE) shares fell 8.9% to $0.1749 after jumping 25% on Monday.
- MSP Recovery, Inc. (NASDAQ: LIFW) shares fell 7.8% to $0.1867 after declining around 15% on Monday.
- TROOPS, Inc. (NASDAQ: TROO) fell 6.4% to $3.8199.
- Sacks Parente Golf, Inc. (NASDAQ: SPGC) fell 6.3% to $1.2750. The company recently posted a narrower second-quarter loss.
- TD SYNNEX Corporation (NYSE: SNX) fell 5.2% to $96.64. TD Synnex reported a third-quarter revenue decline of 9.1% Y/Y to $13.96 billion, missing the consensus of $14.11 billion.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.